RH Belmaker, Yuly Bersudsky, Alex Mishory et Beersheva Mental Health Center, « Valnoctamide in Mania », ClinicalTrials.gov, United States National Institutes of Health, (consulté le )
Haj-Yehia et Meir Bialer, « Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity », Pharmaceutical Research, vol. 6, no 8, , p. 683–689 (PMID2510141, DOI10.1023/A:1015934321764, S2CID21531402)
Lindekens, Ilse Smolders, Ghous M. Khan et Meir Bialer, « In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy », Pharmaceutical Research, vol. 17, no 11, , p. 1408–1413 (PMID11205735, DOI10.1023/A:1007559208599, S2CID24229165)
Pisani, Fazio, Artesi et Oteri, « Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects », British Journal of Clinical Pharmacology, vol. 34, no 1, , p. 85–87 (PMID1352988, PMCID1381382, DOI10.1111/j.1365-2125.1992.tb04114.x)
Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer, « Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 61, no 4, , p. 442–449 (PMID9129561, DOI10.1016/S0009-9236(97)90194-6, lire en ligne)
Isoherranen, H. Steve White, Brian D. Klein et Michael Roeder, « Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy », Pharmaceutical Research, vol. 20, no 8, , p. 1293–1301 (PMID12948028, DOI10.1023/A:1025069519218, S2CID20755032)
Freifelder, Geiszler et Stone, « Hydrolysis of 5,5-Disubstituted Barbituric Acids », The Journal of Organic Chemistry, vol. 26, no 1, , p. 203–206 (ISSN0022-3263, DOI10.1021/jo01060a048)
Freifelder, Geiszler et Stone, « Hydrolysis of 5,5-Disubstituted Barbituric Acids », The Journal of Organic Chemistry, vol. 26, no 1, , p. 203–206 (ISSN0022-3263, DOI10.1021/jo01060a048)
Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer, « Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 61, no 4, , p. 442–449 (PMID9129561, DOI10.1016/S0009-9236(97)90194-6, lire en ligne)
Harl, « [Clinical Study Of Valnoctamide On 70 Neuropsychiatric Clinic Patients Undergoing Ambulatory Treatment] », La Presse Médicale, vol. 72, , p. 753–754 (PMID14119722)
Haj-Yehia et Meir Bialer, « Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity », Pharmaceutical Research, vol. 6, no 8, , p. 683–689 (PMID2510141, DOI10.1023/A:1015934321764, S2CID21531402)
(pt) Mattos Nda, « [Use of Valnoctamide (nirvanil) in oligophrenic erethics and epileptics] », Hospital (Rio J), vol. 75, no 5, , p. 1701–1704 (PMID5306499)
Lindekens, Ilse Smolders, Ghous M. Khan et Meir Bialer, « In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy », Pharmaceutical Research, vol. 17, no 11, , p. 1408–1413 (PMID11205735, DOI10.1023/A:1007559208599, S2CID24229165)
Pisani, Fazio, Artesi et Oteri, « Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects », British Journal of Clinical Pharmacology, vol. 34, no 1, , p. 85–87 (PMID1352988, PMCID1381382, DOI10.1111/j.1365-2125.1992.tb04114.x)
Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer, « Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 61, no 4, , p. 442–449 (PMID9129561, DOI10.1016/S0009-9236(97)90194-6, lire en ligne)
Isoherranen, H. Steve White, Brian D. Klein et Michael Roeder, « Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy », Pharmaceutical Research, vol. 20, no 8, , p. 1293–1301 (PMID12948028, DOI10.1023/A:1025069519218, S2CID20755032)
Haj-Yehia et Meir Bialer, « Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity », Pharmaceutical Research, vol. 6, no 8, , p. 683–689 (PMID2510141, DOI10.1023/A:1015934321764, S2CID21531402)
Lindekens, Ilse Smolders, Ghous M. Khan et Meir Bialer, « In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy », Pharmaceutical Research, vol. 17, no 11, , p. 1408–1413 (PMID11205735, DOI10.1023/A:1007559208599, S2CID24229165)
Isoherranen, H. Steve White, Brian D. Klein et Michael Roeder, « Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy », Pharmaceutical Research, vol. 20, no 8, , p. 1293–1301 (PMID12948028, DOI10.1023/A:1025069519218, S2CID20755032)